Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure
To access this article, please choose from the options below
Funded by Wyeth as the sponsor of the RECOVER trial and by CIC-INSERM-CHU of Nancy for the biomarker substudy.
PII: S1071-9164(08)00081-X
doi:10.1016/j.cardfail.2008.02.014
© 2008 Elsevier Inc. All rights reserved.
